Menu ×


Allergy Immunotherapy Market Segmentation by Treatment (Subcutaneous Immunotherapy and Sublingual Immunotherapy); by Allergy Type (Allergic Rhinitis, Asthma, Allergic Conjunctivitis, and Others); and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) – Global Demand Analysis & Opportunity Outlook 2030

  • Text Size:

Extensive insights into the Growth of Allergy Immunotherapy Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More


·   March 2020: Allergopharma, a subsidiary of Merck, was divested to Dermapharm Holding SE. With this divestment, the allergy treatment business of Merck in Europe was transferred to Dermapharm Holding SE. 

·   August 2018: HAL Allergy B.V. announced that it had got the marketing authorization for SUBLIVAC Birch 40.000 AUN/ml and SUBLIVAC Trees 40.000 AUN/ml in Germany. These two preparations are used for the treatment of allergic rhinitis and rhino-conjunctivitis in adults.

Global Allergy Immunotherapy Market Highlights over 2022 – 2030

The global allergy immunotherapy market is estimated to grow at a CAGR of ~8.7% over the forecast period, i.e., 2022 – 2030. The growth of the market can be attributed to the increasing occurrence of allergic diseases globally, along with high demand for innovative allergic treatment procedures. Additionally, the rise in the prevalence of allergic conditions, such as food allergies, dust and pollen allergies, and others, is leading to the increased demand for immunotherapy. According to a report by the U.S. National Library of Medicine, 10% of the population in western countries, is challenge-diagnosed with food allergies, and the highest prevalence is noted amongst younger children. Moreover, the rising pollution levels, abnormal weather extremities linked to climate change, and increasing presence of dust particles in the environment, are some of the primary factors behind the increasing incidences of lung-related allergies. Such allergies, can also cause severe health-issues, such as, asthma amongst the patients. According to the World Health Organization statistics, asthma affected about 262 million individuals in 2019 worldwide and resulted in 461,000 deaths. Furthermore, surge in adoption of oral immunotherapy, along with the rising investment in medical R&D activities are projected to boost the market growth.

Allergy Immunotherapy Market

The market is bifurcated by treatment into subcutaneous immunotherapy, and sublingual immunotherapy out of which, the subcutaneous immunotherapy segment is anticipated to hold the notable share in the global allergy immunotherapy market over the forecast period as this therapy reduces the use of anti-allergic medication during the pollen season. Moreover, subcutaneous immunotherapy is highly efficiency in treating a wide varieties of allergies, including allergic rhinitis, seasonal pollinosis, house dust, and mite allergy. Such factors are estimated to boost the segment growth. CLICK TO DOWNLOAD SAMPLE REPORT

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Allergy Immunotherapy Market Regional Synopsis

On the basis of geographical analysis, the global allergy immunotherapy market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific region is estimated to witness modest growth over the forecast period on the back of presence of large share of young population which are more vulnerable to the allergic conditions, in countries, such as, India & China.

The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the high rate of prevalence of allergic conditions in the region, combined with higher health awareness amongst the population. According to the World Allergy Organization, allergic rhinitis affects 10-30% of the general adult population and about 40% of children in the US and is considered the fifth most common chronic disease in the country.

Allergy Immunotherapy Market

The global allergy immunotherapy market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global allergy immunotherapy market includes the following segments:

By Treatment

  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy

By Allergy Type

  • Allergic Rhinitis
  • Asthma
  • Allergic Conjunctivitis
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Growth Drivers

  • Increase in Occurrence of Allergic Diseases
  • High Demand for Innovative Allergic Treatment Procedures


  • Limitations Associated with Applicability of Allergy Immunotherapy
  • Poor Efficacy and Specificity of Immunotherapy
  • Risk of Potential Side Effects of Subcutaneous Injections

Top Featured Companies Dominating the Market

  • Leti Pharma S.L.U.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Allergopharma GmbH
  • Stallergenes Greer Ltd.
  • HAL Allergy B.V.
  • HollisterStier Allergy (Jubilant Pharma)
  • Torii Pharmaceutical Co.,Ltd
  • ALK Abelló A/S
  • Allergy Therapeutics
  • Allovate, LLC
  • Circassia Group PLC


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved